Document is current

Any future updates will be listed below

780 ALTA-002, a SIRPα-directed TLR9 agonist antibody conjugate activates myeloid cells and promotes anti-tumor immunity

Crossref DOI link: https://doi.org/10.1136/jitc-2021-SITC2021.780

Published Online: 2021-11-10

Published Print: 2021-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark